RGEN stock news · Repligen Corporation
Get alerts for RGEN
Follow Repligen Corporation (RGEN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for RGENFree on the App Store and Google Play, or on the web.
Repligen plans to buy back shares and issued $1.0 billion in new convertible notes.
NeutralRepligen will raise $458.6 million in cash through new convertible notes and use some to buy back shares. Debt and possible share conversion balance the cash benefit, leaving its outlook unchanged.
BioLife Solutions Inc has finished merging with Repligen Corporation.
NeutralRepligen completed a deal that gives BioLife holders cash and Repligen shares. The filing reports the exchange but no resulting business gains or costs, so this alone does not change how we read Repligen.
Repligen Corp has finished buying BioLife Sciences, which will no longer operate on its own.
NeutralRepligen completed its purchase of BioLife, paying cash and Repligen shares to BioLife owners. The filing gives no expected business gains, so it does not change the outlook.